Principal Financial Group Inc. Grows Position in Astera Labs, Inc. $ALAB

Principal Financial Group Inc. grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 18.3% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,307 shares of the company’s stock after purchasing an additional 4,385 shares during the quarter. Principal Financial Group Inc.’s holdings in Astera Labs were worth $3,102,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of ALAB. Gables Capital Management Inc. purchased a new position in shares of Astera Labs in the first quarter worth about $438,000. Carnegie Investment Counsel lifted its stake in shares of Astera Labs by 26.0% during the 1st quarter. Carnegie Investment Counsel now owns 76,119 shares of the company’s stock valued at $8,343,000 after buying an additional 15,710 shares in the last quarter. Fifth Third Bancorp lifted its stake in shares of Astera Labs by 122,693.2% during the 1st quarter. Fifth Third Bancorp now owns 54,029 shares of the company’s stock valued at $5,922,000 after buying an additional 53,985 shares in the last quarter. Warm Springs Advisors Inc. bought a new position in Astera Labs in the 1st quarter worth approximately $2,908,000. Finally, Hsbc Holdings PLC boosted its holdings in Astera Labs by 116.5% in the 1st quarter. Hsbc Holdings PLC now owns 181,297 shares of the company’s stock worth $19,808,000 after buying an additional 97,576 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer owned 3,929,183 shares in the company, valued at $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on ALAB shares. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. UBS Group increased their target price on Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research report on Monday, June 29th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Citigroup reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday. Finally, Rothschild & Co Redburn began coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $282.00.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $249.74 on Thursday. The firm has a market capitalization of $42.81 billion, a PE ratio of 168.74, a price-to-earnings-growth ratio of 3.01 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a fifty day moving average of $359.85 and a 200 day moving average of $228.24.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter last year, the business posted $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.